Nasal Allergies (Rhinitis)



Role of Montelukast in Asthma and Allergic Rhinitis Patients


Condition:   Asthma and Allergic Rhinitis
Intervention:   Drug: Montelukast 10mg
Sponsor:   Clinision
Not yet recruiting


Benjakul Extract and Loratadine for Treatment Allergic Rhinitis Patients


Condition:   Allergic Rhinitis
Interventions:   Drug: Benjakul Extract;   Drug: Loratadine
Sponsor:   Thammasat University
Recruiting


A Novel Biologic Therapy for Perennial Allergic Rhinitis


Condition:   Allergic Rhinitis
Interventions:   Drug: Allergen Immunotherapy Extract;   Drug: Allergen Immunotherapy Control
Sponsor:   Johns Hopkins University
Recruiting


Nebulized Resveratrol Plus Carboxymethyl-β-Glucan for Reducing IL-5 in Children With Allergic Rhinitis


Condition:   Allergic Rhinitis
Interventions:   Drug: Resveratrol plus Carboxymethyl-β-Glucan;   Drug: Placebo
Sponsor:   Istituto di Biomedicina e Immunologia Molecolare Alberto Monroy
Recruiting


Integrative Omics Approach to Allergic Rhinitis


Condition:   Allergic Rhinitis
Intervention:  
Sponsors:   Medical University of Graz;   Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Not yet recruiting


Effect of Air Cleaner on the Indoor Allergen Sensitized Allergic Rhinitis Patients


Condition:   Allergic Rhinitis
Interventions:   Device: PuriCare (HEPA Air Cleaner);   Device: Mock device of PuriCare
Sponsor:   Yonsei University
Recruiting


Validation of an Allergic Rhinitis Control Test in Children


Condition:   Allergic Rhinitis
Intervention:   Other: Self Questionnaire
Sponsor:   University Hospital, Montpellier
Recruiting


Cellulose Powder Against Grass Pollen Allergic Rhinitis


Condition:   Allergic Rhinitis
Interventions:   Device: Nasaleze;   Device: Placebo
Sponsors:   Nasaleze International Ltd;   Göteborg University
Completed


Efficacy and Safety of So-Cheong-Ryong-Tang on Perennial Allergic Rhinitis


Condition:   Perennial Allergic Rhinitis
Interventions:   Drug: SCRT;   Drug: Placebos
Sponsors:   Kyung Hee University Hospital at Gangdong;   Kyung Hee University Hospital;   Pusan National University Hospital;   Semyung University Affiliated Oriental Medical Hospital;   DongGuk University
Recruiting


Efficacy and Safety of the Mometasone Nasal Gel in the Treatment of Persistent Allergic Rhinitis


Condition:   Allergic Rhinitis
Interventions:   Drug: EMS Mometasone gel;   Drug: Mometasone spray nasal
Sponsor:   EMS
Not yet recruiting


Efficacy and Safety of the Mometasone Nasal Gel in the Treatment of Persistent Allergic Rhinitis


Condition:   Allergic Rhinitis
Interventions:   Drug: EMS Mometasone gel;   Drug: Mometasone spray nasal
Sponsor:   EMS
Not yet recruiting


Long Term Safety and Efficacy of Fixed Dose Combination GSP 301 Nasal Spray (NS) in the Treatment of Perennial Allergic Rhinitis (PAR)


Condition:   Perennial Allergic Rhinitis
Interventions:   Drug: GSP 301 NS;   Drug: GSP 301 Placebo NS pH 3.7;   Drug: GSP 301 Placebo NS pH 7
Sponsor:   Glenmark Specialty S.A.
Completed


Intralymphatic Immunotherapy for House Dust Mite, Dog, and Cat Allergy Using Tyrosine S® in Allergic Rhinitis


Condition:   Allergic Rhinitis
Interventions:   Biological: ILIT with extract of causal allergen;   Biological: ILIT with normal saline;   Drug: Rescue medication for allergic rhinitis
Sponsors:   Gachon University Gil Medical Center;   Korea Research Foundation
Recruiting


Nebulized Beclometasone Dipropionate Improves Nasal Patency in Children With Allergic Rhinitis


Condition:   Allergic Rhinitis
Interventions:   Drug: Nasal Beclomethasone Dipropionate;   Drug: CERCHIO 10 mg/ml OS
Sponsor:   Stefania La Grutta, MD
Completed


Efficacy and Safety of Fixed Dose Combination GSP 301 Nasal Spray (NS) in the Treatment of Seasonal Allergic Rhinitis (SAR)


Condition:   Seasonal Allergic Rhinitis
Interventions:   Drug: GSP 301 NS;   Drug: GOM NS;   Drug: GMM-2 NS;   Drug: GSP 301 Placebo NS
Sponsor:   Glenmark Specialty S.A.
Completed


Treatment of Sanfu Herbal Patch for Allergic Rhinitis: a Controlled Clinical Trial


Condition:   Allergic Rhinitis
Interventions:   Drug: Sanfu herbal patch;   Drug: Sanfu moxibustion;   Drug: Sanfu herbal patch and moxibustion
Sponsor:   Hubei Provincial Collaborative Innovation Center of Preventive Treatment by Acupuncture and Moxibust
Recruiting


Quality of Life in Patients With Allergic Rhinitis: Clinical Trial With Bilastine or Loratadine


Condition:   Allergic Rhinitis
Interventions:   Drug: Bilastine;   Drug: Loratadine
Sponsor:   Universidade do Sul de Santa Catarina
Completed


Trial of Tian Jiu Therapy for Allergic Rhinitis


Condition:   Allergic Rhinitis (AR)
Interventions:   Drug: herbal patches of Tian Jiu group;   Drug: placebo patches of placebo-control group
Sponsor:   Hong Kong Baptist University
Completed


Nasal Budesonide Efficacy on Nasal FeNO in Children With Allergic Rhinitis


Condition:   Allergic Rhinitis
Interventions:   Drug: Budesonide nasal spray (100 mcg bid);   Drug: Budesonide nasal spray (50 mcg bid
Sponsor:   Istituto di Biomedicina e Immunologia Molecolare Alberto Monroy
Completed


The Efficacy and Safety of Sanfujiu on Patients With Persistent Allergic Rhinitis: Randomized Controlled Study


Condition:   Allergic Rhinitis
Interventions:   Drug: Sanfujiu;   Drug: Placebo
Sponsor:   Guangdong Provincial Hospital of Traditional Chinese Medicine
Active, not recruiting


Pilot Study to Evaluate Ear Acupressure Effects in Treating Seasonal Allergic Rhinitis


Condition:   Seasonal Allergic Rhinitis
Intervention:   Device: acupressure pellets
Sponsor:   University of Mississippi Medical Center
Terminated


A Study of the Efficacy and Safety of Desloratadine (MK-4117) in Japanese Participants With Perennial Allergic Rhinitis (MK-4117-200)


Condition:   Perennial Allergic Rhinitis
Interventions:   Drug: Desloratadine 5 mg;   Drug: Placebo
Sponsor:   Merck Sharp & Dohme Corp.
Completed


A Study to Evaluate the Safety of Combination Montelukast/Loratadine in Mexican Participants With Allergic Rhinitis (MK-0476A-484)


Condition:   Allergic Rhinitis
Interventions:   Drug: Montelukast 10 mg/loratadine 10 mg;   Drug: Placebo
Sponsor:   Merck Sharp & Dohme Corp.
Completed


Onset of Effect of Mometasone Nasal Spray in Induced Allergic Rhinitis (Study P03431)


Condition:   Allergic Rhinitis
Interventions:   Drug: Mometasone;   Drug: Placebo
Sponsor:   Merck Sharp & Dohme Corp.
Completed


An Exploratory Study of the Effects of a Single Dose of QAX576 (an Interleukin-13 Monoclonal Antibody) on Simulated Hayfever


Condition:   Allergic Rhinitis
Interventions:   Drug: QAX576;   Drug: Placebo
Sponsor:   Novartis
Completed

Refine Your Search Advanced Search